Luke Bury

Stem Cell Biologist Trailhead Biosystems

Seminars

Wednesday 4th February 2026
The Need for High-Purity A9 Dopaminergic Neurons Within Parkinson’s Disease Models
12:20 pm
  • Understand the biological significance of A9 vs. A10 dopaminergic neuron subtypes in Parkinson’s disease
  • Learn how HD-DoE technology enables targeted development of A9 neurons with desired phenotypic profiles
  • Review of key phenotypic and functional QC benchmarks
  • Discussion of recommended use cases and applications in discovery and disease modeling
Luke Bury, Stem Cell Biologist, Trailhead